WSWA
GILD icon

Warren Street Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Warren Street Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Buy
2,119
+192
+10% +$25.3K 0.06% 113
2026
Q1 		$269K Buy
1,927
+56
+3% +$7.84K 0.07% 100
2025
Q4 		$230K Sell
1,871
-50
-3% -$6.08K 0.07% 99
2025
Q3 		$213K Buy
1,921
+90
+5% +$10.2K 0.06% 141
2025
Q2 		$203K Buy
+1,831
New +$195K 0.07% 133

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Warren Street Wealth Advisors's GILD Position: Q2 2026 in Review

Warren Street Wealth Advisors increased its Gilead Sciences (GILD) stake by 10% in Q2 2026, buying an estimated $25.3K and bringing the position to 2,119 shares worth $268K. The position accounts for 0.06% of the portfolio, ranked #113.

Warren Street Wealth Advisors first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $269K in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Warren Street Wealth Advisors held 2,119 shares of Gilead Sciences worth $268K as of Q2 2026.
  • Warren Street Wealth Advisors bought 192 Gilead Sciences shares in Q2 2026, an estimated $25.3K.
  • Gilead Sciences made up 0.06% of Warren Street Wealth Advisors's portfolio in Q2 2026, its #113 holding.
  • Warren Street Wealth Advisors first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Warren Street Wealth Advisors's Gilead Sciences position peaked at $269K in Q1 2026.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Warren Street Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.